Mangoceuticals annual return on equity
2023
2024
2025
Mangoceuticals Return on Equity (ROE) Growth & History (MGRX)
Mangoceuticals's return on equity was −141.65% for fiscal 2025.
View full Mangoceuticals company overviewMangoceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −141.65% | −23.37 pp |
| 2024 | 2024-12-31 | −118.28% | +1208.41 pp |
| 2023 | 2023-12-31 | −1,326.69% | — |
Mangoceuticals quarterly return on equity
Q1.23
Q2.23
Q3.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10.10% | +17.33 pp |
| Q1 2026 | 2026-03-31 | −23.73% | +4.57 pp |
| Q4 2025 | 2025-12-31 | −17.91% | −3.65 pp |
| Q3 2025 | 2025-09-30 | −43.57% | −28.88 pp |
| Q2 2025 | 2025-06-30 | −27.43% | +9.73 pp |
| Q1 2025 | 2025-03-31 | −28.30% | — |
| Q4 2024 | 2024-12-31 | −14.26% | +226.92 pp |
| Q3 2024 | 2024-09-30 | −14.69% | +67.90 pp |
| Q2 2024 | 2024-06-30 | −37.15% | +29.81 pp |
| Q4 2023 | 2023-12-31 | −241.18% | — |
| Q3 2023 | 2023-09-30 | −82.59% | — |
| Q2 2023 | 2023-06-30 | −66.96% | — |
| Q1 2023 | 2023-03-31 | −115.53% | — |
Mangoceuticals return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Mangoceuticals's return on equity increased from −1,326.69% to −141.65%, a change of +1185.04 percentage points. The latest reported quarter, Q2 2026, shows −10.10%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mangoceuticals source filings ↗